Shareholders of FTSE 100 hospital operator NMC Health (LSE: NMC) saw the value of their stock fall by more than 30% in the week before Christmas after US short seller Muddy Waters released a highly critical report on the firm.
Muddy Waters report contains allegations of accounting irregularities. NMC has strenuously denied any such irregularities, but I suspect that many investors will be concerned about this situation and unsure how to act.
In this article Im going to take a broader look at NMC and give my view on the stock. Ill also consider the outlook for another FTSE 100 stock with a strong track record of growth.
Whats the story?
NMC Health is the largest private healthcare operator in the UAE. According to the firm, its also amongst the leading fertility service providers in the world. Last year, 87.6% of revenue came from the UAE. The remainder came from a mix of operations in Western Europe and elsewhere in the Middle East.
NMC is 46 years old, but only listed on the London Stock Exchange in 2012. This listing was followed by explosive growth that saw the groups revenue quadruple from $551m in 2013 to $2,057m in 2018.
Profits rose by 265% from $69.1m to $252m over the same period, and between January 2013 and December 2018, the share price rose by 1,289%!
Although its publicly listed, 51% of the groups shares are held by three individuals, including two board directors. This suggests to me that smaller investors, including UK fund managers, are unlikely to have much influence on how the company is run.
Should you buy NMC?
The firm has made a lot of money for early investors who held on to their shares. But the groups rapid expansion has been fuelled by debt my analysis shows that net debt has risen from $63.7m to $1,521m since 2013.
In fairness, this business does seem to generate plenty of cash. But it spends a lot too. Im concerned about what will happen when the groups double-digit annual growth rate starts to slow.
The stocks recent fall has left it looking more reasonably valued, on about 15 times 2019 forecast earnings.
However, I feel that the firms high degree of leverage and its overseas focus add risk for UK investors and make the outlook harder to assess. Ive put this stock in the too difficult pile and will continue to avoid it in 2020.
One stock Ive been buying
Im more bullish about cruise ship operator Carnival (LSE: CCL). This FTSE 100 firm is the largest company in this fast-growing sector, but the Carnival share price has fallen by 25% over the last two years.
Rising costs and one-off political events have hit the groups operating margin, which fell by almost 2% to 15.7% last year. However, I still see this as an attractive level of profitability that reflects the groups market-leading scale.
Looking ahead, the company says that bookings so far for 2020 are at record levels, in terms of occupancy.
I think that the Carnival share price probably got ahead of itself when it peaked at over 50 in 2017. But with the price now hovering around 37, the stock trades on just 11 times forecast earnings with a 4.2% dividend yield. I think this looks decent value. Ive been adding the shares to my own portfolio in recent months.
Theres a double agent hiding in the FTSE
We recommend you buy it!
You can now read our new stock presentation.
It contains details of a UK-listed company our Motley Fool UK analysts are extremely enthusiastic about.
They think its offering an incredible opportunity to grow your wealth over the long term at its current price regardless of what happens in the wider market.
Thats why theyre referring to it as the FTSEs double agent.
Because they believe its working both with the market And against it.
To find out why we think you should add it to your portfolio today
